Syensqo Ventures, the group’s venture capital fund, participated in the $2.1 million financing round for Bioeutectics, alongside Fen Ventures, Atento Capital and SOSV (IndieBio).
This new investment strengthens the existing partnership between Syensqo Ventures and the Genesis Consortium, supporting startups in the SOSV’s IndieBio startup development program, the #1 early stage biotech incubator.
Syensqo, through its Renewable Materials and Biotechnology growth platform, is driven by a strong commitment to develop more sustainable solutions in the food, agro, industrial and biopharma sectors.
Based on pioneering technology - Natural Deep Eutectic Solvents (NADES), Bioeutetics mimics the way plants elaborate their own solvents, using 100% renewable sources. By replacing petrochemical-based solvents with natural alternatives, Bioeutectics provides solvents with an improved environmental, health, and safety profile that are aligned with and contribute to the achievement of sustainable development goals.